These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 24481322)

  • 21. Trends in serum cotinine concentrations among daily cigarette smokers: data from NHANES 1999-2010.
    Jain RB
    Sci Total Environ; 2014 Feb; 472():72-7. PubMed ID: 24291557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carboxyhaemoglobin levels, health and lifestyle perceptions in smokers converting from tobacco cigarettes to electronic cigarettes.
    van Staden SR; Groenewald M; Engelbrecht R; Becker PJ; Hazelhurst LT
    S Afr Med J; 2013 Sep; 103(11):865-8. PubMed ID: 24148175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of body mass index and total blood volume on serum cotinine levels among cigarette smokers: NHANES 1999-2008.
    Jain RB; Bernert JT
    Clin Chim Acta; 2010 Aug; 411(15-16):1063-8. PubMed ID: 20361952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in nicotine intake and cigarette use over time in two nationally representative cross-sectional samples of smokers.
    O'Connor RJ; Giovino GA; Kozlowski LT; Shiffman S; Hyland A; Bernert JT; Caraballo RS; Cummings KM
    Am J Epidemiol; 2006 Oct; 164(8):750-9. PubMed ID: 16887891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anxiety disorders and cigarette smoking: Results from the Australian Survey of Mental Health and Wellbeing.
    Lawrence D; Considine J; Mitrou F; Zubrick SR
    Aust N Z J Psychiatry; 2010 Jun; 44(6):520-7. PubMed ID: 20482412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Smoking, nicotine dependence and psychiatric comorbidity--a population-based study including smoking cessation after three years.
    John U; Meyer C; Rumpf HJ; Hapke U
    Drug Alcohol Depend; 2004 Dec; 76(3):287-95. PubMed ID: 15561479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stages of change, smoking characteristics, and cotinine concentrations in smokers: setting priorities for smoking cessation.
    Fu M; Fernández E; Pascual JA; Martínez-Sánchez JM; Agudo A; Moncada A; Nebot M; Borràs JM;
    Prev Med; 2011 Feb; 52(2):139-45. PubMed ID: 21163297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Negative affectivity in smokers applying to smoking cessation clinics: a case-control study.
    Cosci F; Schruers KR; Pistelli F; Griez EJ
    Depress Anxiety; 2009; 26(9):824-30. PubMed ID: 19105219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insomnia and sleep duration in a large cohort of patients with major depressive disorder and anxiety disorders.
    van Mill JG; Hoogendijk WJ; Vogelzangs N; van Dyck R; Penninx BW
    J Clin Psychiatry; 2010 Mar; 71(3):239-46. PubMed ID: 20331928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nicotine patch therapy in 101 adolescent smokers: efficacy, withdrawal symptom relief, and carbon monoxide and plasma cotinine levels.
    Hurt RD; Croghan GA; Beede SD; Wolter TD; Croghan IT; Patten CA
    Arch Pediatr Adolesc Med; 2000 Jan; 154(1):31-7. PubMed ID: 10632247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-term benefit of smoking cessation in patients with coronary heart disease: estimates based on self-reported smoking data and serum cotinine measurements.
    Twardella D; Küpper-Nybelen J; Rothenbacher D; Hahmann H; Wüsten B; Brenner H
    Eur Heart J; 2004 Dec; 25(23):2101-8. PubMed ID: 15571825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The validation of self-reported smoking status by analysing cotinine levels in stimulated and unstimulated saliva, serum and urine.
    Binnie V; McHugh S; Macpherson L; Borland B; Moir K; Malik K
    Oral Dis; 2004 Sep; 10(5):287-93. PubMed ID: 15315646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nicotine patch therapy in adolescent smokers.
    Smith TA; House RF; Croghan IT; Gauvin TR; Colligan RC; Offord KP; Gomez-Dahl LC; Hurt RD
    Pediatrics; 1996 Oct; 98(4 Pt 1):659-67. PubMed ID: 8885942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. No increased levels of the nicotine metabolite cotinine in smokers with schizophrenia.
    Bozikas VP; Niopas I; Kafantari A; Kanaze FI; Gabrieli C; Melissidis P; Gamvrula K; Fokas K; Karavatos A
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):1-6. PubMed ID: 15610938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apparent underreporting of cigarette consumption among Mexican American smokers.
    Pérez-Stable EJ; Marín BV; Marín G; Brody DJ; Benowitz NL
    Am J Public Health; 1990 Sep; 80(9):1057-61. PubMed ID: 2382741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytokine production capacity in depression and anxiety.
    Vogelzangs N; de Jonge P; Smit JH; Bahn S; Penninx BW
    Transl Psychiatry; 2016 May; 6(5):e825. PubMed ID: 27244234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-treatment cigarette demand among treatment-seeking smokers with depressive symptoms.
    Weidberg S; Vallejo-Seco G; González-Roz A; García-Pérez Á; Secades-Villa R
    Addict Behav; 2018 Jul; 82():35-43. PubMed ID: 29482033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet monoamine oxidase B activity is inversely associated with plasma cotinine concentration.
    Berlin I; Spreux-Varoquaux O; Launay JM
    Nicotine Tob Res; 2000 Aug; 2(3):243-6. PubMed ID: 11082824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Misclassification of smoking status by self-reported cigarette consumption.
    Pérez-Stable EJ; Marín G; Marín BV; Benowitz NL
    Am Rev Respir Dis; 1992 Jan; 145(1):53-7. PubMed ID: 1731599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depression and smoking: examining correlates in a subset of depressed patients.
    Roy K; Parker G; Mitchell P; Wilhelm K
    Aust N Z J Psychiatry; 2001 Jun; 35(3):329-35. PubMed ID: 11437806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.